PBS - HOW TO USE THIS DOCUMENTThis measure ... · Web view2019/04/08 · tacrolimus 1 mg modified...
Transcript of PBS - HOW TO USE THIS DOCUMENTThis measure ... · Web view2019/04/08 · tacrolimus 1 mg modified...
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
ATTACHMENT: INCREASED DISPENSING QUANTITIES - LIST OF MEDICINES
This attachment includes the medicines recommended as suitable by the PBAC for listing on the PBS with increased dispensed quantities. Please note that some strengths, forms and indications of a medicine may not be included in the recommended list below. The PBS item codes in this document are those listed on the PBS Schedule effective 1 July 2018.
Table 1: PBS medicines found suitable by the PBAC for listing with additional item codes for increased dispensed quantities (143 medicines/348 PBS item codes).
Table 2: PBS medicines currently available under the 12 month repeat measure found suitable for amendment in accordance with the PBAC recommendations for increased dispensed quantities (19 medicines/41 PBS item codes).
TABLE OF CONTENTS (MEDICINES ARRANGED ALPHANUMERICALLY WITHIN BODY SYSTEM GROUPS):
HOW TO USE THIS DOCUMENT page 2TABLE 1:
1.1 ALIMENTARY TRACT & METABOLISM page 61.2 BLOOD & DERMATOLOGICALS page 91.3 CARDIOVASCULAR SYSTEM page 111.4 RENIN-ANGIOTENSIN & LIPID AGENTS page 211.5 HORMONAL MODULATORS page 401.6 IMMUNOMODULATING & OTHER AGENTS page 421.7 MUSCULO-SKELETAL SYSTEM page 451.8 NERVOUS SYSTEM page 471.9 RESPIRATORY SYSTEM page 481.10 SENSORY ORGANS page 491.11 VARIOUS MEDICINES page 51
TABLE 2:2.1 AMENDED LISTINGS page 52
1
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
HOW TO USE THIS DOCUMENT
This measure includes an extensive list of medicines.
To find out if a specific medicine is included in this measure, follow ONE of TWO methods detailed below:
METHOD ONE:
1. Hold the ‘Ctrl’ key (for Windows) or ‘Command’ key (for Mac) key while pressing the ‘F’ key on the keyboard.
2. The following search box should appear in the document:
a. Use the mouse to click on the ‘Find’ line within this box:
b. Type in the medicine name or brand then press ‘Next’.
2
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
3. The document will highlight the medicine or brand that was typed in ‘Find’.
3
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
4. If no matches were found within the document, it is likely that the medicine or brand is not included in this measure.
4
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
METHOD TWO:
1. If you know which ‘Body System’ your medicine belongs in, click on the corresponding ‘Body System’ from the contents page of this document.
2. The document will go to the corresponding ‘Body System’ page, from there, the medications are ordered alphanumerically.
5
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
TABLE 1: The following PBS medicines/item codes were found suitable by the PBAC for listing with additional item codes for increased dispensed quantities.
1.1 ALIMENTARY TRACT & METABOLISMMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)balsalazide sodium 750 mg capsule, 280 11351K Colazide Ulcerative colitis
bisacodyl 10 mg suppository, 10 1260H Petrus Bisacodyl SuppositoriesDulcolax
M - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
bisacodyl 10 mg suppository, 12 1258F Petrus Bisacodyl SuppositoriesM - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
bisacodyl 10 mg/5 mL enema, 25 x 5 mL 1263L BisalaxM - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
bisacodyl 5 mg enteric tablet, 200 1259G Lax-TabM - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
calcitriol 0.25 microgram capsule, 100 2502Q
APO-CalcitriolCalciproxCalcitriol ANKosteoSicalRocaltrol
M - hypocalcaemia, hypoparathyroidism, hypophosphataemic rickets, Vitamin-D resistant Rickets, established osteoporosis
macrogol-3350 1 g/g oral liquid: powder for, 30 x 17 g sachets 2373X Herron ClearLax M - constipation (4 different clinical criteria),
faecal impaction
macrogol-3350 1 g/g powder for oral liquid, 510 g 3416T OsmoLax M - constipation (4 different clinical criteria), faecal impaction
6
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
macrogol-3350 13.12 g + sodium chloride 350.7 mg + potassium chloride 46.6 mg (0.63 mmol potassium) + sodium bicarbonate 178.5 mg solution, 30 sachets
8612G
APO-MACROGOL plus ELECTROLYTESChemists' Own Macrogol with ElectrolytesLaxaConMacrovicMolaxoleMovicollax-sachets
M - constipation (4 different clinical criteria), faecal impaction
macrogol-3350 13.12 g/25 mL + sodium chloride 350.7 mg/25 mL + potassium chloride 46.6 mg/25 mL (0.63mmol/25 mL potassium) + sodium bicarbonate 178.5 mg/25 mL oral liquid, 500 mL
10126Y Movicol Liquid M - constipation (4 different clinical criteria), faecal impaction
mesalazine 1 g modified release granules, 100 sachets 8599N Salofalk Ulcerative colitis
mesalazine 1 g modified release granules, 120 sachets 2234N Pentasa M - ulcerative colitis, crohn disease
mesalazine 1 g modified release tablet, 60 3413P Pentasa M - ulcerative colitis, crohn diseasemesalazine 1.2 g modified release tablet, 60 9353G Mezavant Ulcerative colitismesalazine 1.5 g modified release granules, 60 sachets 9206M Salofalk Ulcerative colitis
mesalazine 2 g modified release granules, 60 sachets 2287J Pentasa M - ulcerative colitis, crohn disease
mesalazine 250 mg enteric tablet, 100 1611T Mesasal M - ulcerative colitis, crohn diseasemesalazine 3 g modified release granules, 30 sachets 10257W Salofalk Ulcerative colitis
mesalazine 4 g modified release granules, 30 sachets 10254Q Pentasa Ulcerative colitis
mesalazine 500 mg enteric tablet, 100 8731M Salofalk M - ulcerative colitis, crohn diseasemesalazine 500 mg modified release granules, 100 sachets 8598M Salofalk Ulcerative colitis
mesalazine 500 mg modified release tablet, 100 2214M Pentasa M - ulcerative colitis, crohn diseasemesalazine 800 mg enteric tablet, 90 11210B Asacol Ulcerative colitisolsalazine sodium 250 mg capsule, 100 1728Y Dipentum Ulcerative colitisolsalazine sodium 500 mg tablet, 100 8086N Dipentum Ulcerative colitisMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
7
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
rhamnus frangula 80 mg/g + sterculia 620 mg/g granules, 500 g 1104D Normacol Plus
M - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
sodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL
2091C MicoletteM - constipation (4 different clinical/population criteria), terminal malignant neoplasia, anorectal congenital abnormalities, megacolon
thiamine hydrochloride 100 mg tablet, 100 1070H Betavit Thiamine deficiency (for ATSI population)
8
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.2 BLOOD & DERMATOLOGICALSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
clopidogrel 75 mg + aspirin 100 mg tablet, 30 9296G
APO-Clopidogrel/Aspirin 75/100CLOPIDOGREL/ASPIRIN AN 75/100Chem mart Clopidogrel/Aspirin 75/100Clopidogrel Winthrop plus aspirinClopidogrel/Aspirin Actavis 75/100Clopidogrel/Aspirin Sandoz 75/100CoPlavixDuoCoverDuoPlidogrelPiax Plus AspirinTerry White Chemists Clopidogrel/Aspirin 75/100
M - acute coronary syndrome (myocardial infarction or unstable angina), cardiac stent insertion, prevention of recurrence of myocardial infarction or unstable angina
clopidogrel 75 mg tablet, 28 2275R
Clopidogrel GHClopidogrel-GAClovix 75Plidogrel
M - acute coronary syndrome (myocardial infarction or unstable angina), cardiac stent insertion
clopidogrel 75 mg tablet, 28 8358X
APO-ClopidogrelBlooms the Chemist ClopidogrelChem mart ClopidogrelClopidogrel ANClopidogrel SandozClopidogrel WinthropIscoverPiaxPlavicor 75PlavixTerry White Chemists Clopidogrel
M - prevention of recurrence of myocardial infarction or unstable angina (3 clinical criteria), Prevention of recurrence of ischaemic stroke or transient cerebral ischaemic events (3 clinical criteria)
9
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
clopidogrel 75 mg tablet, 28 9317J
APO-ClopidogrelBlooms the Chemist ClopidogrelChem mart ClopidogrelClopidogrel ANClopidogrel SandozClopidogrel WinthropIscoverPiaxPlavixTerry White Chemists Clopidogrel
M - acute coronary syndrome (myocardial infarction or unstable angina), cardiac syent insertion
clopidogrel 75 mg tablet, 28 9354H
Clopidogrel GHClopidogrel-GAClovix 75Plidogrel
M - prevention of recurrence of myocardial infarction or unstable angina (3 clinical criteria), Prevention of recurrence of ischaemic stroke or transient cerebral ischaemic events (3 clinical criteria)
coal tar prepared 2% foam, 100 g 10225E Scytera
dipyridamole 200 mg + aspirin 25 mg modified release capsule, 60 8382E Asasantin SR
Diasp SRPrevention of recurrence of ischaemic stroke or transient cerebral ischaemic events
dipyridamole 200 mg modified release capsule, 60 8335Q Persantin SR
Prevention of recurrence of ischaemic stroke or transient cerebral ischaemic events (3 clinical criteria)
prasugrel 10 mg tablet, 28 9496T Effient Acute coronary syndrome (myocardial infarction or unstable angina)
prasugrel 5 mg tablet, 28 9495R Effient Acute coronary syndrome (myocardial infarction or unstable angina)
ticagrelor 90 mg tablet, 56 1418P Brilinta Acute coronary syndrome (myocardial infarction or unstable angina)
10
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.3 CARDIOVASCULAR SYSTEMMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)amiloride hydrochloride dihydrate 5 mg + hydrochlorothiazide 50 mg tablet, 50 1486F Moduretic
amlodipine 10 mg tablet, 30 2752W
APO-AmlodipineAmlo 10Amlodipine ANAmlodipine AmnealAmlodipine GHAmlodipine SandozAuro-Amlodipine 10Blooms the Chemist AmlodipineChem mart AmlodipineNordipNorvapinePharmacor AmlodipineTerry White Chemists AmlodipineNorvasc
amlodipine 5 mg tablet, 30 2751T
APO-AmlodipineAmlo 5Amlodipine ANAmlodipine AmnealAmlodipine GHAmlodipine SandozAuro-Amlodipine 5Blooms the Chemist AmlodipineChem mart AmlodipineNordipNorvapinePharmacor AmlodipineTerry White Chemists AmlodipineNorvasc
11
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
atenolol 50 mg tablet, 30 1081X
APO-AtenololAtenolol AmnealAtenolol GHAtenolol SandozAtenolol-GAChem mart AtenololNotenTenolten 50TensigTerry White Chemists AtenololTenormin
atenolol 50 mg/10 mL oral liquid, 300 mL 2243C Atenolol-AFT For patients who are unable to take a solid dose form of atenolol.
bisoprolol fumarate 10 mg tablet, 28 8606Y
APO-BisoprololBeprol 10Bicard 10Bisoprolol ANBisoprolol SandozBisoprolol generichealthBispro 10Chem mart BisoprololTerry White Chemists BisoprololBicor
Moderate to severe heart failure
bisoprolol fumarate 2.5 mg tablet, 28 8604W
APO-BisoprololBeprol 2.5Bicard 2.5Bisoprolol ANBisoprolol SandozBisoprolol generichealthBispro 2.5Chem mart BisoprololTerry White Chemists BisoprololBicor
Moderate to severe heart failure
12
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
bisoprolol fumarate 5 mg tablet, 28 8605X
APO-BisoprololBeprol 5Bicard 5Bisoprolol ANBisoprolol SandozBisoprolol generichealthBispro 5Chem mart BisoprololTerry White Chemists BisoprololBicor
Moderate to severe heart failure
carvedilol 12.5 mg tablet, 60 8257N
APO-CarvedilolCarvedilol ANCarvedilol SandozDicarzDilatrend 12.5Vedilol 12.5Volirop 12.5
M - moderate to severe heart failure, patients receiving this drug as a PBS benefit prior to August 2002
carvedilol 25 mg tablet, 60 8258P
APO-CarvedilolCarvedilol ANCarvedilol SandozDicarzDilatrend 25Vedilol 25Volirop 25
M - moderate to severe heart failure, patients receiving this drug as a PBS benefit prior to August 2002
carvedilol 6.25 mg tablet, 60 8256M
APO-CarvedilolCarvedilol ANCarvedilol SandozDicarzDilatrend 6.25Vedilol 6.25Volirop 6.25
M - moderate to severe heart failure, patients receiving this drug as a PBS benefit prior to August 2002
chlortalidone 25 mg tablet, 50 1585K Hygroton 25 clonidine hydrochloride 100 microgram tablet, 100 3145M APO-Clonidine
Catapres 100
13
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)clonidine hydrochloride 150 microgram tablet, 100 3141H Catapres
diltiazem hydrochloride 180 mg modified release capsule, 30 1312C
Diltiazem Sandoz CDVasocardol CDCardizem CD
diltiazem hydrochloride 240 mg modified release capsule, 30 1313D
Diltiazem Sandoz CDVasocardol CDCardizem CD
diltiazem hydrochloride 360 mg modified release capsule, 30 8480H
Diltiazem Sandoz CDVasocardol CDCardizem CD
diltiazem hydrochloride 60 mg tablet, 90 1335G
Diltiazem ANDiltiazem ActavisDiltiazem SandozCardizemVasocardol
felodipine 10 mg modified release tablet, 30 2367N
Felodil XR 10Felodur ER 10 mgFendex ERPlendil ER
felodipine 2.5 mg modified release tablet, 30 2361GFelodur ER 2.5 mgFendex ERPlendil ER
felodipine 5 mg modified release tablet, 30 2366M
Felodil XR 5Felodur ER 5 mgFendex ERPlendil ER
furosemide (frusemide) 10 mg/mL oral liquid, 30 mL 2411X Lasix
furosemide (frusemide) 20 mg tablet, 100 2414C
APO-FrusemideChem mart FrusemideFUROSEMIDE ANTerry White Chemists Frusemide
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
14
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
furosemide (frusemide) 20 mg tablet, 50 1810G Urex-MLasix-M
furosemide (frusemide) 40 mg tablet, 100 2412Y
APO-FrusemideChem mart FrusemideFUROSEMIDE ANFrusaxFrusemide SandozTerry White Chemists FrusemideUremideUrexLasix
furosemide (frusemide) 500 mg tablet, 50 2415D Urex-Forte glyceryl trinitrate 10 mg/24 hours patch, 30 1516T Transiderm-Nitro 50 glyceryl trinitrate 10 mg/24 hours patch, 30 8028M Minitran 10 glyceryl trinitrate 15 mg/24 hours patch, 30 8119H Minitran 15 glyceryl trinitrate 300 microgram sublingual tablet, 100 11027J Nitrostat
glyceryl trinitrate 400 microgram/actuation oral spray, 200 actuations 8171C Nitrolingual Pumpspray
glyceryl trinitrate 5 mg/24 hours patch, 30 1515R Transiderm-Nitro 25 glyceryl trinitrate 5 mg/24 hours patch, 30 8027L Minitran 5
glyceryl trinitrate 600 microgram sublingual tablet, 100 1459T
LycinateNitrostatAnginine Stabilised
hydralazine hydrochloride 25 mg tablet, 100 1640H Alphapress 25 hydralazine hydrochloride 50 mg tablet, 100 1639G Alphapress 50 hydrochlorothiazide 25 mg + triamterene 50 mg tablet, 100 1280J Hydrene 25/50
hydrochlorothiazide 25 mg tablet, 100 1484D Dithiazide
15
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
indapamide hemihydrate 1.5 mg modified release tablet, 90 8532C
APO-Indapamide SRChem mart Indapamide SRINDAPAMIDE AN SROdaplix SRTenaxil SRTerry White Chemists Indapamide SRNatrilix SR
indapamide hemihydrate 2.5 mg tablet, 90 2436F
Dapa-TabsGenRx IndapamideIndapamide ANIndapamide SandozInsigNatrilix
isosorbide dinitrate 5 mg sublingual tablet, 100 2588F Isordil Sublingual isosorbide mononitrate 120 mg modified release tablet, 30 8273K Monodur 120 mg
Imdur 120 mg
isosorbide mononitrate 60 mg modified release tablet, 30 1558B
Chem mart Isosorbide MononitrateDurideGenRx Isosorbide MononitrateIsomonitIsosorbide ANTerry White Chemists Isosorbide MononitrateImdur DuruleMonodur 60 mg
ivabradine 5 mg tablet, 56 10012Y APO-IvabradineCoralan Chronic heart failure
ivabradine 7.5 mg tablet, 56 2960T APO-IvabradineCoralan Chronic heart failure
labetalol hydrochloride 100 mg tablet, 100 1566K Presolol 100Trandate
labetalol hydrochloride 200 mg tablet, 100 1567L Presolol 200Trandate
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
16
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
lercanidipine hydrochloride 10 mg tablet, 28 8534E
APO-LercanidipineBlooms the Chemist LercanidipineChem mart LercanidipineLercadipLercanLercanidipine SandozTerry White Chemists LercanidipineZircolZircol 10Zanidip
lercanidipine hydrochloride 20 mg tablet, 28 8679T
APO-LercanidipineBlooms the Chemist LercanidipineChem mart LercanidipineLercadipLercanLercanidipine GHLercanidipine SandozTerry White Chemists LercanidipineZircolZircol 20Zanidip
methyldopa 250 mg tablet, 100 1629R HydopaAldomet
metoprolol succinate tablet 190 mg (controlled release), 30 8735R
Metrol-XL 190Minax XLToprol-XL 190
Moderate to severe heart failure
metoprolol succinate tablet 47.5 mg (controlled release), 30 8733P
Metrol-XL 47.5Minax XLToprol-XL 47.5
Moderate to severe heart failure
metoprolol succinate tablet 95 mg (controlled release), 30 8734Q
Metrol-XL 95Minax XLToprol-XL 95
Moderate to severe heart failure
17
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
metoprolol tartrate tablet 100 mg, 60 1325R
APO-MetoprololChem mart MetoprololMetoprolol ANMetoprolol SandozMetrol 100Minax 100MistromTerry White Chemists MetoprololBetalocLopresor 100
metoprolol tartrate tablet 50 mg, 100 1324Q
APO-MetoprololChem mart MetoprololMetoprolol ANMetoprolol SandozMetrol 50Minax 50MistromTerry White Chemists MetoprololBetalocLopresor 50
moxonidine 200 microgram tablet, 30 9019Q
APO-MoxonidineMoxonidine GHMoxonidine GXMoxonidine MYLPhysiotens
Hypertension
moxonidine 400 microgram tablet, 30 9020R
APO-MoxonidineMoxonidine GHMoxonidine GXMoxonidine MYLPhysiotens
Hypertension
nebivolol 10mg tablet, 28 9312D APO-NebivololNebilet Moderate to severe heart failure
nebivolol 5 mg tablet, 28 9311C APO-NebivololNebilet Moderate to severe heart failure
18
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
nicorandil 10 mg tablet, 60 8228C IkorelIkotab
nicorandil 20 mg tablet, 60 8229D IkorelIkotab
nifedipine 10 mg tablet, 60 1694E Adefin 10 nifedipine 20 mg modified release tablet, 30 8610E Adalat Oros 20mg nifedipine 20 mg tablet, 60 1695F Adefin 20
nifedipine 30 mg modified release tablet, 30 1906H
APO-Nifedipine XRAddos XR 30Adefin XL 30Adalat Oros 30
nifedipine 60 mg modified release tablet, 30 1907J
APO-Nifedipine XRAddos XR 60Adefin XL 60Adalat Oros 60
oxprenolol hydrochloride 40 mg tablet, 100 2961W Corbeton 40 pindolol 5 mg tablet, 100 3062E Barbloc 5
prazosin 1 mg tablet, 100 1479W APO-PrazosinMinipress
prazosin 2 mg tablet, 100 1480X APO-PrazosinMinipress
prazosin 5 mg tablet, 100 1478T APO-PrazosinMinipress
propranolol hydrochloride 10 mg tablet, 100 2565BAPO-PropranololInderalDeralin 10
propranolol hydrochloride 160 mg tablet, 50 2899N Deralin 160
propranolol hydrochloride 40 mg tablet, 100 2566CAPO-PropranololInderalDeralin 40
verapamil hydrochloride 180 mg modified release tablet, 30 2208F Cordilox 180 SR
Isoptin 180 SR
19
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)verapamil hydrochloride 240 mg modified release tablet, 30 1241H Cordilox SR
Isoptin SR
verapamil hydrochloride 40 mg tablet, 100 1248Q Anpec 40
verapamil hydrochloride 80 mg tablet, 100 1250T Anpec 80Isoptin
20
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.4 RENIN-ANGIOTENSIN & LIPID AGENTSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
amlodipine 10 mg + atorvastatin 10 mg tablet, 30 9053L Cadivast 10/10Caduet 10/10
amlodipine 10 mg + atorvastatin 20 mg tablet, 30 9054M Cadivast 10/20Caduet 10/20
amlodipine 10 mg + atorvastatin 40 mg tablet, 30 9055N Cadivast 10/40Caduet 10/40
amlodipine 10 mg + atorvastatin 80 mg tablet, 30 9056P Cadivast 10/80Caduet 10/80
amlodipine 10 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28 5287G
Valsartan/Amlodipine/HCT Novartis 160/10/12.5Exforge HCT 10/160/12.5
Hypertension
amlodipine 10 mg + valsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28 5288H
Valsartan/Amlodipine/HCT Novartis 160/10/25Exforge HCT 10/160/25
Hypertension
amlodipine 10 mg + valsartan 160 mg tablet, 28 9377M Valsartan/Amlodipine Novartis 160/10Exforge 10/160 Hypertension
amlodipine 5 mg + atorvastatin 10 mg tablet, 30 9049G Cadivast 5/10 amlodipine 5 mg + atorvastatin 20 mg tablet, 30 9050H Cadivast 5/20
amlodipine 5 mg + atorvastatin 40 mg tablet, 30 9051J Cadivast 5/40Caduet 5/40
amlodipine 5 mg + atorvastatin 80 mg tablet, 30 9052K Cadivast 5/80Caduet 5/80
amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28 5285E
Valsartan/Amlodipine/HCT Novartis 160/5/12.5Exforge HCT 5/160/12.5
Hypertension
amlodipine 5 mg + valsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28 5286F
Valsartan/Amlodipine/HCT Novartis 160/5/25Exforge HCT 5/160/25
Hypertension
amlodipine 5 mg + valsartan 160 mg tablet, 28 9376L Valsartan/Amlodipine Novartis 160/5Exforge 5/160 Hypertension
amlodipine 5 mg + valsartan 320 mg tablet, 28 5459H Valsartan/Amlodipine Novartis 320/5Exforge 5/320 Hypertension
21
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
amlodipine 5 mg + valsartan 80 mg tablet, 28 9375K Valsartan/Amlodipine Novartis 80/5Exforge 5/80 Hypertension
candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 8504N
APO-Candesartan HCTZ 16/12.5Adesan HCT 16/12.5Asartan HCT 16/12.5Blooms the Chemist Candesartan HCTZ 16/12.5CANDESAN COMBI 16/12.5Candesartan Combi Aspen 16/12.5Candesartan HCT GH 16/12.5Candesartan HCTZ AN 16/12.5Candesartan/HCT SandozChem mart Candesartan HCTZ 16/12.5Terry White Chemists Candesartan HCTZ 16/12.5Atacand Plus 16/12.5
Hypertension
candesartan cilexetil 16 mg tablet, 30 8297Q
APO-CandesartanAdesanBlooms the Chemist CandesartanCANDESANCandesartan ANCandesartan Aspen 16Candesartan GHCandesartan SandozChem mart CandesartanTerry White Chemists CandesartanAtacand
22
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 9314F
APO-Candesartan HCTZ 32/12.5Adesan HCT 32/12.5Asartan HCT 32/12.5Blooms the Chemist Candesartan HCTZ 32/12.5CANDESAN COMBI 32/12.5Candesartan Combi Aspen 32/12.5Candesartan HCT GH 32/12.5Candesartan HCTZ AN 32/12.5Candesartan/HCT SandozChem mart Candesartan HCTZ 32/12.5Terry White Chemists Candesartan HCTZ 32/12.5Atacand Plus 32/12.5
Hypertension
candesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 9315G
APO-Candesartan HCTZ 32/25Adesan HCT 32/25Asartan HCT 32/25Blooms the Chemist Candesartan HCTZ 32/25CANDESAN COMBI 32/25Candesartan Combi Aspen 32/25Candesartan HCT GH 32/25Candesartan HCTZ AN 32/25Candesartan/HCT SandozChem mart Candesartan HCTZ 32/25Terry White Chemists Candesartan HCTZ 32/25Atacand Plus 32/25
Hypertension
23
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
candesartan cilexetil 32 mg tablet, 30 8889W
APO-CandesartanAdesanBlooms the Chemist CandesartanCANDESANCandesartan ANCandesartan Aspen 32Candesartan GHCandesartan SandozChem mart CandesartanTerry White Chemists CandesartanAtacand
candesartan cilexetil 4 mg tablet, 30 8295N
APO-CandesartanAdesanBlooms the Chemist CandesartanCANDESANCandesartan ANCandesartan Aspen 4Candesartan SandozChem mart CandesartanTerry White Chemists CandesartanAtacand
candesartan cilexetil 8 mg tablet, 30 8296P
APO-CandesartanAdesanBlooms the Chemist CandesartanCANDESANCandesartan ANCandesartan Aspen 8Candesartan SandozChem mart CandesartanTerry White Chemists CandesartanAtacand
captopril 12.5 mg tablet, 90 1147J Captopril SandozZedace
24
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
captopril 25 mg tablet, 90 1148KCaptopril SandozCapotenZedace
captopril 5 mg/mL oral liquid, 95 mL 8760C Capoten Patients unable to take a solid dose form of an ACE inhibitor.
captopril 50 mg tablet, 90 1149LCaptopril SandozCapotenZedace
enalapril maleate 10 mg tablet, 30 1368B
APO-EnalaprilAcetecEnalapril ActavisEnalapril SandozEnalapril generichealthMaleanRenitec
enalapril maleate 20 mg + hydrochlorothiazide 6 mg tablet, 30 8477E Enalapril/HCT Sandoz
Renitec Plus 20/6 Hypertension
enalapril maleate 20 mg tablet, 30 1369C
APO-EnalaprilAcetecEnalapril ActavisEnalapril SandozEnalapril generichealthMaleanRenitec 20
enalapril maleate 5 mg tablet, 30 1370D
APO-EnalaprilAcetecEnalapril ActavisEnalapril SandozEnalapril generichealthMalean
eprosartan 400 mg tablet, 28 8397Y Teveten
25
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
eprosartan 400 mg tablet, 28 8951D Teveten
M - adverse effects/drug interaction occurring/drug interactions expected to occur with all of the base-priced drugs (3 clinical criteria), transfer to a base-priced drug would cause patient confusion resulting in problems with compliance
eprosartan 600 mg + hydrochlorothiazide 12.5 mg tablet, 28 8624X Teveten Plus 600/12.5 Hypertension
eprosartan 600 mg tablet, 28 5491B Teveten
M - adverse effects/drug interaction occurring/drug interactions expected to occur with all of the base-priced drugs (3 clinical criteria), transfer to a base-priced drug would cause patient confusion resulting in problems with compliance
eprosartan 600 mg tablet, 28 8447N Teveten ezetimibe 10 mg + atorvastatin 10 mg tablet, 30 10392Y Atozet Hypercholesterolaemiaezetimibe 10 mg + atorvastatin 20 mg tablet, 30 10393B Atozet Hypercholesterolaemiaezetimibe 10 mg + atorvastatin 40 mg tablet, 30 10377E Atozet Hypercholesterolaemiaezetimibe 10 mg + atorvastatin 80 mg tablet, 30 10376D Atozet Hypercholesterolaemia
ezetimibe 10 mg + simvastatin 10 mg tablet, 30 9483D
APO-Ezetimibe/Simvastatin 10/10EZETIMIBE/SIMVASTATIN SANDOZVytorinZeklen 10/10 mg
Hypercholesterolaemia
ezetimibe 10 mg + simvastatin 20 mg tablet, 30 9484E
APO-Ezetimibe/Simvastatin 10/20EZETIMIBE/SIMVASTATIN SANDOZVytorinZeklen 10/20 mg
Hypercholesterolaemia
ezetimibe 10 mg + simvastatin 40 mg tablet, 30 8881K
APO-Ezetimibe/Simvastatin 10/40EZETIMIBE/SIMVASTATIN SANDOZVytorinZeklen 10/40 mg
Hypercholesterolaemia
26
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
ezetimibe 10 mg + simvastatin 80 mg tablet, 30 8882L
APO-Ezetimibe/Simvastatin 10/80EZETIMIBE/SIMVASTATIN SANDOZVytorinZeklen 10/80 mg
Hypercholesterolaemia
ezetimibe 10 mg tablet, 30 11408K
EZEMICHOLEzetrolPharmacor Ezetimibe 10Zient 10mg
Hypercholesterolaemia
ezetimibe 10 mg tablet, 30 8757X
APO-EzetimibeBlooms The Chemist EzetimibeEZEMICHOLEzetimibe GHEzetimibe SandozEzetrolPharmacor Ezetimibe 10Zient 10mg
M - hypercholesterolaemia (2 clinical criteria)
fosinopril sodium 10 mg tablet, 30 1182FAPO-FosinoprilFosipril 10Monace 10
fosinopril sodium 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 8401E
APO-Fosinopril HCTZ 20/12.5Fosetic 20/12.5Fosinopril/HCT Actavis 20/12.5
Hypertension
fosinopril sodium 20 mg tablet, 30 1183GAPO-FosinoprilFosipril 20Monace 20
27
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 8404H
APO-Irbesartan HCTZAVSARTAN HCT 150/12.5Abisart HCT 150/12.5Abisart HCTZ 150/12.5Blooms the Chemist Irbesartan HCTZ 150/12.5Chem mart Irbesartan HCTZIrbesartan HCT Actavis 150/12.5Irbesartan HCT GH 150/12.5Irbesartan HCTZ AMNEALIrbesartan/HCT SandozKSART HCT 150/12.5Terry White Chemists Irbesartan HCTZKarvezide 150/12.5Avapro HCT 150/12.5
Hypertension
irbesartan 150 mg tablet, 30 8247C
APO-IrbesartanAVSARTANAbisartAbisart 150Blooms the Chemist IrbesartanChem mart IrbesartanIrbesartan AMNEALIrbesartan ANIrbesartan Actavis 150Irbesartan GHIrbesartan SandozIrprestan 150Terry White Chemists IrbesartanKarveaAvapro
28
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 8405J
APO-Irbesartan HCTZAVSARTAN HCT 300/12.5Abisart HCT 300/12.5Abisart HCTZ 300/12.5Blooms the Chemist Irbesartan HCTZ 300/12.5Chem mart Irbesartan HCTZIrbesartan HCT Actavis 300/12.5Irbesartan HCT GH 300/12.5Irbesartan HCTZ AMNEALIrbesartan/HCT SandozKSART HCT 300/12.5Terry White Chemists Irbesartan HCTZKarvezide 300/12.5Avapro HCT 300/12.5
Hypertension
irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 2136K
APO-Irbesartan HCTZAVSARTAN HCT 300/25Abisart HCT 300/25Abisart HCTZ 300/25Blooms the Chemist Irbesartan HCTZ 300/25Chem mart Irbesartan HCTZIrbesartan HCT Actavis 300/25Irbesartan HCT GH 300/25Irbesartan HCTZ AMNEALIrbesartan/HCT SandozKSART HCT 300/25Terry White Chemists Irbesartan Avapro HCT 300/25Karvezide 300/25
Hypertension
29
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
irbesartan 300 mg tablet, 30 8248D
APO-IrbesartanAVSARTANAbisartAbisart 300Blooms the Chemist IrbesartanChem mart IrbesartanIrbesartan AMNEALIrbesartan ANIrbesartan Actavis 300Irbesartan GHIrbesartan SandozIrprestan 300Terry White Chemists IrbesartanKarveaAvapro
irbesartan 75 mg tablet, 30 8246B
APO-IrbesartanAVSARTANAbisartAbisart 75Blooms the Chemist IrbesartanChem mart IrbesartanIrbesartan AMNEALIrbesartan ANIrbesartan Actavis 75Irbesartan GHIrbesartan SandozIrprestan 75Terry White Chemists IrbesartanKarveaAvapro
lercanidipine hydrochloride 10 mg + enalapril maleate 10 mg tablet, 28 9144G Zan-Extra 10/10 Hypertension
lercanidipine hydrochloride 10 mg + enalapril maleate 20 mg tablet, 28 9145H Zan-Extra 10/20 Hypertension
30
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
lisinopril 10 mg tablet, 30 2457H
APO-LisinoprilAuro-Lisinopril 10Fibsol 10Lisinopril ANLisinopril SandozLisinopril generichealthZinopril 10Zestril
lisinopril 20 mg tablet, 30 2458J
APO-LisinoprilAuro-Lisinopril 20Fibsol 20Lisinopril ANLisinopril SandozLisinopril generichealthZinopril 20Zestril
lisinopril 5 mg tablet, 30 2456G
APO-LisinoprilAuro-Lisinopril 5Fibsol 5Lisinopril ANLisinopril SandozLisinopril generichealthZinopril 5Zestril
losartan potassium 25 mg tablet, 30 5452Y Cozavan losartan potassium 50 mg tablet, 30 8203R Cozavan olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 10005N Sevikar HCT 20/5/12.5 Hypertension
olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 5292M Olmesartan/Amlodipine - MYL 20/5
Sevikar 20/5 Hypertension
31
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
olmesartan medoxomil 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 2161R
APO-Olmesartan/HCTZ 20/12.5OLMERTAN COMBI 20/12.5Olmesartan HCT - MYL 20/12.5Olmesartan HCT AN 20/12.5Olmesartan/HCT SandozPharmacor Olmesartan HCTZ 20/12.5Olmetec Plus
Hypertension
olmesartan medoxomil 20 mg tablet, 30 2147B
APO-OlmesartanOLMERTANOlmesartan - MYLOlmesartan ANOlmesartan SandozPharmacor Olmesartan 20Olmetec
olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 2836G Sevikar HCT 40/10/12.5 Hypertension
olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 2953K Sevikar HCT 40/10/25 Hypertension
olmesartan medoxomil 40 mg + amlodipine 10 mg tablet, 30 5294P Olmesartan/Amlodipine - MYL 40/10
Sevikar 40/10 Hypertension
olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 2880N Sevikar HCT 40/5/12.5 Hypertension
olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 2864R Sevikar HCT 40/5/25 Hypertension
olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 5293N Olmesartan/Amlodipine - MYL 40/5
Sevikar 40/5 Hypertension
olmesartan medoxomil 40 mg + hydrochlorothiazide 12.5 mg tablet, 30 2166B
APO-Olmesartan/HCTZ 40/12.5OLMERTAN COMBI 40/12.5Olmesartan HCT - MYL 40/12.5Olmesartan HCT AN 40/12.5Olmesartan/HCT SandozPharmacor Olmesartan HCTZ 40/12.5Olmetec Plus
Hypertension
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
32
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
olmesartan medoxomil 40 mg + hydrochlorothiazide 25 mg tablet, 30 2170F
APO-Olmesartan/HCTZ 40/25OLMERTAN COMBI 40/25Olmesartan HCT - MYL 40/25Olmesartan HCT AN 40/25Olmesartan/HCT SandozPharmacor Olmesartan HCTZ 40/25Olmetec Plus
Hypertension
olmesartan medoxomil 40 mg tablet, 30 2148C
APO-OlmesartanOLMERTANOlmesartan - MYLOlmesartan ANOlmesartan SandozPharmacor Olmesartan 40Olmetec
perindopril arginine 10 mg + amlodipine 10 mg tablet, 30 9349C
APO-Perindopril Arginine/Amlodipine 10/10Reaptan 10/10Coveram 10/10
M - hypertension, stable coronary heart disease
perindopril arginine 10 mg + amlodipine 5 mg tablet, 30 9348B
APO-Perindopril Arginine/Amlodipine 10/5Reaptan 10/5Coveram 10/5
M - hypertension, stable coronary heart disease
perindopril arginine 10 mg tablet, 30 9008DAPO-Perindopril ArgininePREXUM 10Coversyl 10mg
perindopril arginine 2.5 mg + indapamide hemihydrate 625 microgram tablet, 30 2190G PREXUM Combi LD 2.5/0.625
Coversyl Plus LD 2.5mg/0.625mg
perindopril arginine 2.5 mg tablet, 30 9006BAPO-Perindopril ArgininePREXUM 2.5Coversyl 2.5mg
perindopril arginine 5 mg + amlodipine 10 mg tablet, 30 9347Y
APO-Perindopril Arginine/Amlodipine 5/10Reaptan 5/10Coveram 5/10
M - hypertension, stable coronary heart disease
33
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
perindopril arginine 5 mg + amlodipine 5 mg tablet, 30 9346X
APO-Perindopril Arginine/Amlodipine 5/5Reaptan 5/5Coveram 5/5
M - hypertension, stable coronary heart disease
perindopril arginine 5 mg + indapamide hemihydrate 1.25 mg tablet, 30 2845R Prexum Combi 5/1.25
Coversyl Plus 5mg/1.25mg Hypertension
perindopril arginine 5 mg tablet, 30 9007CAPO-Perindopril ArgininePREXUM 5Coversyl 5mg
quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 8589C Accuretic 10/12.5mg Hypertension
quinapril 10 mg tablet, 30 1969P
ACQUINAPO-QuinaprilAcquin Aspen 10Qpril 10Accupril
quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 8590D Accuretic 20/12.5mg Hypertension
quinapril 20 mg tablet, 30 1970Q
ACQUINAPO-QuinaprilAcquin Aspen 20Qpril 20Quinapril generichealthAccupril
quinapril 5 mg tablet, 30 1968N
ACQUINAcquin Aspen 5Qpril 5Accupril
ramipril 1.25 mg capsule, 30 9120B APO-RamiprilTryzan Caps 1.25
34
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
ramipril 1.25 mg tablet, 30 1944H
Ramace 1.25 mgRamipril SandozRamipril WinthropTritace 1.25 mgTryzan Tabs 1.25
ramipril 10 mg capsule, 30 8470T
APO-RamiprilChem mart RamiprilRamace 10 mgRamipril ANRamipril SandozRamipril WinthropTerry White Chemists RamiprilTritace 10 mgTryzan Caps 10
ramipril 10 mg tablet, 30 1316G
APO-RamiprilChem mart RamiprilRamipril ANRamipril SandozTerry White Chemists RamiprilTritaceTryzan Tabs 10
ramipril 2.5 mg + felodipine 2.5 mg modified release tablet, 30 2626F Triasyn 2.5/2.5 Hypertension
ramipril 2.5 mg capsule, 30 9121C
APO-RamiprilChem mart RamiprilTerry White Chemists RamiprilTryzan Caps 2.5
35
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
ramipril 2.5 mg tablet, 30 1945J
APO-RamiprilChem mart RamiprilRamace 2.5 mgRamipril ANRamipril SandozRamipril WinthropTerry White Chemists RamiprilTritace 2.5 mgTryzan Tabs 2.5
ramipril 5 mg + felodipine 5 mg modified release tablet, 30 2629J Triasyn 5.0/5.0 Hypertension
ramipril 5 mg capsule, 30 9122D
APO-RamiprilChem mart RamiprilTerry White Chemists RamiprilTryzan Caps 5
ramipril 5 mg tablet, 30 1946K
APO-RamiprilChem mart RamiprilRamace 5 mgRamipril ANRamipril SandozRamipril WinthropTerry White Chemists RamiprilTritace 5 mgTryzan Tabs 5
rosuvastatin 10 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack 10208G Ezalo Composite Pack 10mg+10mg
Rosuzet Composite Pack Hypercholesterolaemia
rosuvastatin 20 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack 10201X Ezalo Composite Pack 10mg+20mg
Rosuzet Composite Pack Hypercholesterolaemia
rosuvastatin 40 mg tablet [30] (&) ezetimibe 10 mg tablet [30 tablets], 1 pack 10207F Ezalo Composite Pack 10mg+40mg
Rosuzet Composite Pack Hypercholesterolaemia
rosuvastatin 5 mg tablet [30] (&) ezetimibe 10 mg tablet [30], 1 pack 10204C Ezalo Composite Pack 10mg+5mg
Rosuzet Composite Pack Hypercholesterolaemia
sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 11123K Entresto Chronic heart failureMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
36
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 11131W Entresto Chronic heart failure
sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 11122J Entresto Chronic heart failure
telmisartan 40 mg + amlodipine 10 mg tablet, 28 8979N Pritor/AmlodipineTwynsta Hypertension
telmisartan 40 mg + amlodipine 5 mg tablet, 28 8978M Pritor/AmlodipineTwynsta Hypertension
telmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet, 28 8622T
APO-Telmisartan HCTZ 40/12.5Mizart HCT 40/12.5 mgTelmisartan HCT GH 40/12.5Telmisartan HCTZ AN 40/12.5Telmisartan/HCT SandozTeltartan HCT 40/12.5Micardis Plus 40/12.5 mg
Hypertension
telmisartan 40 mg tablet, 28 8355R
APO-TelmisartanMizartPharmacor Telmisartan 40Telmisartan ANTelmisartan GHTelmisartan SandozTelmisartan-DRLATeltartanMicardis
telmisartan 80 mg + amlodipine 10 mg tablet, 28 8981Q Pritor/AmlodipineTwynsta Hypertension
telmisartan 80 mg + amlodipine 5 mg tablet, 28 8980P Pritor/AmlodipineTwynsta Hypertension
37
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
telmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 8623W
APO-Telmisartan HCTZ 80/12.5Mizart HCT 80/12.5 mgTelmisartan HCT GH 80/12.5Telmisartan HCTZ AN 80/12.5Telmisartan/HCT SandozTeltartan HCT 80/12.5Micardis Plus 80/12.5 mg
Hypertension
telmisartan 80 mg + hydrochlorothiazide 25 mg tablet, 28 9381R
APO-Telmisartan HCTZ 80/25Mizart HCT 80/25 mgTelmisartan HCT GH 80/25Telmisartan HCTZ AN 80/25Telmisartan/HCT SandozTeltartan HCT 80/25Micardis Plus 80/25 mg
Hypertension
telmisartan 80 mg tablet, 28 8356T
APO-TelmisartanMizartPharmacor Telmisartan 80Telmisartan ANTelmisartan GHTelmisartan SandozTelmisartan-DRLATeltartanMicardis
trandolapril 1 mg capsule, 28 2792YDolapril 1TranalphaGopten
trandolapril 2 mg + verapamil hydrochloride 180 mg modified release tablet, 28 9387C Tarka 2/180 Hypertension
trandolapril 2 mg capsule, 28 2793BDolapril 2TranalphaGopten
trandolapril 4 mg + verapamil hydrochloride 240 mg modified release tablet, 28 2857J Tarka 4/240 Hypertension
38
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
trandolapril 4 mg capsule, 28 8758YDolapril 4TranalphaGopten
trandolapril 500 microgram capsule, 28 2791XDolapril 0.5TranalphaGopten
valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28 9373H Co-Diovan 160/12.5 Hypertension
valsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28 9374J Co-Diovan 160/25 Hypertension
valsartan 160 mg tablet, 28 9370E Diovan valsartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 9372G Co-Diovan 80/12.5 Hypertension
valsartan 80 mg tablet, 28 9369D Diovan
39
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.5 HORMONAL MODULATORSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
bromocriptine 2.5 mg tablet, 30 1443Y Parlodel M - acromegaly, parkinsons disease, pathological hyperprolactinaemia (4 clinical criteria)
cabergoline 500 microgram tablet, 8 8114C APO-CabergolineDostinex
M - pathological hyperprolactinaemia (4 clinical criteria)
dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30
5490Y Duodart 500ug/400ug Benign prostatic hyperplasia
dutasteride 500 microgram capsule, 30 5468T APO-DutasterideAvodart Benign prostatic hyperplasia
estradiol 0.1% (1 mg/g) gel, 28 x 1 g sachets 8286D Sandrena estradiol 1 mg + dydrogesterone 5 mg tablet, 28 10142T Femoston-Conti estradiol 1 mg tablet [14] (&) estradiol 1 mg + dydrogesterone 10 mg tablet [14], 28 10146B Femoston 1/10
estradiol 10 microgram modified release pessary, 18 10203B Vagifem Low
estradiol 100 microgram/24 hours patch, 4 8126Q Climara 100 estradiol 100 microgram/24 hours patch, 8 8312L Estraderm MX 100 estradiol 100 microgram/24 hours patch, 8 8765H Estradot 100 estradiol 2 mg tablet [14] (&) estradiol 2 mg + dydrogesterone 10 mg tablet [14], 28 8244X Femoston 2/10
estradiol 2 mg tablet, 56 8274L Zumenon estradiol 25 microgram/24 hours patch, 4 8485N Climara 25 estradiol 25 microgram/24 hours patch, 8 8311K Estraderm MX 25 estradiol 25 microgram/24 hours patch, 8 8761D Estradot 25 estradiol 37.5 microgram/24 hours patch, 8 8762E Estradot 37.5 estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8
8427M Estalis continuous 50/140
estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8
8428N Estalis continuous 50/250
40
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)estradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch [4], 8
8425K Estalis sequi 50/140
estradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch [4], 8
8426L Estalis sequi 50/250
estradiol 50 microgram/24 hours patch, 4 8125P Climara 50 estradiol 50 microgram/24 hours patch, 8 8140K Estraderm MX 50 estradiol 50 microgram/24 hours patch, 8 8763F Estradot 50 estradiol 75 microgram/24 hours patch, 4 8486P Climara 75 estradiol 75 microgram/24 hours patch, 8 8764G Estradot 75 estradiol valerate 1 mg tablet, 56 1663M Progynova estradiol valerate 2 mg tablet, 56 1664N Progynova estriol 0.1% (1 mg/g) cream, 15 g 1781R Ovestin estriol 500 microgram pessary, 15 1771F Ovestin Ovula norethisterone 5 mg tablet, 30 2993M Primolut N oxybutynin 3.9 mg/24 hours patch, 8 9454N Oxytrol Detrusor overactivity
oxybutynin hydrochloride 5 mg tablet, 100 8039D DitropanOxybutynin Sandoz Detrusor overactivity
propantheline bromide 15 mg tablet, 100 1953T Pro-Banthine Detrusor overactivity
quinagolide 75 microgram tablet, 30 8822H Norprolac M - pathological hyperprolactinaemia (4 clinical criteria)
41
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.6 IMMUNOMODULATING & OTHER AGENTSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
anastrozole 1 mg tablet, 30 8179L
APO-AnastrozoleAnastrolAnastrozole ANAnastrozole FBMAnastrozole GHAnastrozole SandozArianna 1ArimidexAstzol
Breast cancer
ciclosporin 10 mg capsule, 60 8657P Neoral 10
ciclosporin 100 mg capsule, 30 8660T Cyclosporin SandozNeoral 100
ciclosporin 100 mg/mL oral liquid, 50 mL 8661W Neoral
ciclosporin 25 mg capsule, 30 8658Q Cyclosporin SandozNeoral 25
ciclosporin 50 mg capsule, 30 8659R Cyclosporin SandozNeoral 50
exemestane 25 mg tablet, 30 8506Q
APO-ExemestaneEstamaneExaccordExemestane ANExemestane GHExemestane SandozAromasin
Breast cancer
42
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
letrozole 2.5 mg tablet, 30 8245Y
APO-LetrozoleChem mart LetrozoleFemara 2.5 mgFemoletFeraGynotrilLetrozLetrozole ANLetrozole FBMLetrozole SandozLetrozole generichealthPharmacor Letrozole 2.5Terry White Chemists Letrozole
Breast cancer
tacrolimus 1 mg capsule, 100 8647D
PacrolimPharmacor Tacrolimus 1PrografTACROLIMUS APOTEXTacrografTacrolimus Sandoz
tacrolimus 1 mg modified release capsule, 60 5300Y ADVAGRAF XLPrograf XL
tacrolimus 2 mg capsule, 100 10871E Tacrolimus Sandoz
tacrolimus 5 mg capsule, 50 8648E
PacrolimPharmacor Tacrolimus 5PrografTACROLIMUS APOTEXTacrografTacrolimus Sandoz
tacrolimus 5 mg modified release capsule, 30 5451X ADVAGRAF XLPrograf XL
43
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
tacrolimus 500 microgram capsule, 100 8646C
PacrolimPharmacor Tacrolimus 0.5PrografTACROLIMUS APOTEXTacrografTacrolimus Sandoz
tacrolimus 500 microgram modified release capsule, 30 5299X ADVAGRAF XL
Prograf XL
tacrolimus 750 microgram capsule, 100 10870D Tacrolimus Sandoz tamoxifen 10 mg tablet, 60 2109B Genox 10 Breast cancertoremifene 60 mg tablet, 30 8216K Fareston
44
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.7 MUSCULO-SKELETAL SYSTEMMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
alendronate 70 mg + colecalciferol 140 microgram (5600 units) tablet, 4 9183H
ALENDRONATE PLUS D3 70mg/140ug APOTEXAPO-Alendronate Plus D3 70 mg/140 mcgAlendronate Plus D3 SandozAlendronate plus D3-DRLADronalen PlusFonatPlusFosamax Plus 70 mg/140 mcg
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
alendronate 70 mg + colecalciferol 140 microgram tablet [4] (&) calcium (as carbonate) 500 mg tablet [48], 1 pack
9351EDronalen Plus D-CalReddyMax Plus D-CalFosamax Plus D-Cal
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
alendronate 70 mg + colecalciferol 70 microgram tablet, 4 9012H
ALENDRONATE PLUS D3 70mg/70ug APOTEXAPO-Alendronate Plus D3 70 mg/70 mcgAlendronate Plus D3 SandozAlendronate plus D3-DRLAFonatPlusFosamax Plus
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
alendronate 70 mg tablet, 4 8511Y
APO-AlendronateAlendro Once WeeklyAlendrobell 70mgAlendronate SandozDensate 70Fonat
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
colchicine 500 microgram tablet, 30 3410L LengoutColgout
risedronate sodium 150 mg tablet, 1 9391G
APO-RisedronateATELVIA ONCE-A-MONTHAcris Once-a-MonthActonel Once-a-Month
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
risedronate sodium 35 mg enteric tablet, 4 8972F Actonel EC M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
45
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)risedronate sodium 35 mg tablet [4] (&) calcium (as carbonate) 500 mg tablet [24], 28 8899J Acris Combi M - corticosteroid-induced osteoporosis,
osteoporosis, established osteoporosis
risedronate sodium 35 mg tablet, 4 8621R
APO-RisedronateAcris Once-a-WeekRisedro once a weekRisedronate ANRisedronate Sandoz
M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
risedronate sodium 5 mg tablet, 28 8481J Actonel M - corticosteroid-induced osteoporosis, osteoporosis, established osteoporosis
46
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.8 NERVOUS SYSTEMMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)pizotifen 500 microgram tablet, 100 3074T Sandomigran 0.5
47
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.9 RESPIRATORY SYSTEMMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)aclidinium 322 microgram/actuation inhalation: powder for, 60 actuations 10124W Bretaris Genuair Chronic obstructive pulmonary disease (COPD)
aclidinium 340 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 12 microgram/actuation powder for inhalation, 60 actuations
10565C Brimica Genuair Chronic obstructive pulmonary disease (COPD)
fluticasone furoate 100 microgram/actuation + umeclidinium 62.5 microgram/actuation + vilanterol 25 microgram/actuation powder for inhalation, 30
11379X Trelegy Ellipta 100/62.5/25 Chronic obstructive pulmonary disease (COPD)
glycopyrronium 50 microgram powder for inhalation, 30 capsules 10059K seebri breezhaler Chronic obstructive pulmonary disease (COPD)
indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 30 capsules 10156M ultibro breezhaler 110/50 Chronic obstructive pulmonary disease (COPD)
indacaterol 150 microgram powder for inhalation, 30 capsules 5134F Onbrez Chronic obstructive pulmonary disease (COPD)
indacaterol 300 microgram powder for inhalation, 30 capsules 5137J Onbrez Chronic obstructive pulmonary disease (COPD)
ipratropium bromide 20 microgram/actuation inhalation: pressurised, 200 actuations 8671J Atrovent
tiotropium 18 microgram powder for inhalation, 30 capsules 8626B Spiriva Chronic obstructive pulmonary disease (COPD)
tiotropium 2.5 microgram/actuation + olodaterol 2.5 microgram/actuation inhalation solution, 60 actuations
10557P Spiolto Respimat Chronic obstructive pulmonary disease (COPD)
tiotropium 2.5 microgram/actuation inhalation solution, 60 actuations 10509D Spiriva Respimat Bronchospasm and dyspnoea associated with
chronic obstructive pulmonary diseaseumeclidinium 62.5 microgram/actuation + vilanterol 25 microgram/actuation powder for inhalation, 30 actuations
10188F Anoro Ellipta 62.5/25 Chronic obstructive pulmonary disease (COPD)
umeclidinium 62.5 microgram/actuation inhalation: powder for, 30 actuations 10187E Incruse Ellipta Chronic obstructive pulmonary disease (COPD)
48
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.10 SENSORY ORGANSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
betaxolol 0.5% eye drops, 5 mL 2825Q BetoQuinBetoptic
bimatoprost 0.03% + timolol 0.5% eye drops, 3 mL 9464D Ganfort 0.3/5 Elevated intra-ocular pressure
bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL unit doses 10107Y GANfort PF 0.3/5 Elevated intra-ocular pressure
bimatoprost 0.03% eye drops, 3 mL 8620Q
APO-BimatoprostBimatoprost SandozBimtopLumigan
bimatoprost 0.03% eye drops, 30 x 0.4 mL unit doses 10046R Lumigan PF
brimonidine tartrate 0.15% eye drops, 5 mL 5298W Alphagan P 1.5 brimonidine tartrate 0.2% + timolol 0.5% eye drops, 5 mL 8826M Combigan Elevated intra-ocular pressure
brimonidine tartrate 0.2% eye drops, 5 mL 8351M EnidinAlphagan
dorzolamide 2% + timolol 0.5% eye drops, 5 mL 8567X
APO-Dorzolamide/Timolol 20/5CosdorDORZOLAMIDE/TIMOLOL AN 20/5Cosopt
Elevated intra-ocular pressure
dorzolamide 2% eye drops, 5 mL 8488RAPO-DorzolamideTrusamideTrusopt
latanoprost 0.005% + timolol 0.5% eye drops, 2.5 mL 8895E
APO-Latanoprost/Timolol 0.05/5LantimLatanoprost/Timolol Sandoz 50/5Latanoprost/timolol AN 50/5XalacomXalamol 50/5
Elevated intra-ocular pressure
49
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
latanoprost 0.005% eye drops, 2.5 mL 8243W
APO-LatanoprostLanproLatanoprost ActavisLatanoprost SandozXalaprostXalatan
pilocarpine hydrochloride 1% eye drops, 15 mL 2595N Isopto Carpine pilocarpine hydrochloride 2% eye drops, 15 mL 2596P Isopto Carpine pilocarpine hydrochloride 4% eye drops, 15 mL 2598R Isopto Carpine tafluprost 0.0015% eye drops, 30 x 0.3 mL unit doses 2755B Saflutan
timolol 0.25% eye drops, 2.5 mL 1925H Timoptol XE timolol 0.5% eye drops, 2.5 mL 1926J Timoptol XE timolol 0.5% eye drops, 5 mL 1279H Timoptol travoprost 0.004% + timolol 0.5% eye drops, 2.5 mL 9057Q Duotrav Elevated intra-ocular pressure
travoprost 0.004% eye drops, 2.5 mL 8597L Travatan
50
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
1.11 VARIOUS MEDICINESMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)lanthanum tablet, chewable, 1000 mg (as carbonate hydrate), 90 9405B Fosrenol Hyperphosphataemia
lanthanum tablet, chewable, 500 mg (as carbonate hydrate), 90 9403X Fosrenol Hyperphosphataemia
lanthanum tablet, chewable, 750 mg (as carbonate hydrate), 90 9404Y Fosrenol Hyperphosphataemia
phosphorus 500 mg effervescent tablet, 100 2946C PHOSPHATE PHEBRAPhosphate Sandoz
M - hypophosphataemic rickets, Vitamin D-resistant rickets, familial hypophosphataemia, hypercalcaemia
sevelamer hydrochloride 800 mg tablet, 180 2142R Renagel Hyperphosphataemiasevelamer hydrochloride 800 mg tablet, 180 9546K Renagel Hyperphosphataemiasevelamer hydrochloride 800 mg tablet, 180 9620H Renagel Hyperphosphataemia
51
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
TABLE 2:The following PBS medicines/item codes currently available under the 12 month repeat measure were found suitable for amendment in accordance with the PBAC recommendations for increased dispensed quantities.
2.1 AMENDED LISTINGSMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
atorvastatin 10 mg tablet, 30 9230T
APO-AtorvastatinAtorvacholAtorvastatin AmnealAtorvastatin GHAtorvastatin SZAtorvastatin SandozBlooms the Chemist AtorvastatinChem mart AtorvastatinLipitorLorstat 10Pharmacor AtorvastatinTerry White Chemists AtorvastatinTorvastat 10Trovas
52
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
atorvastatin 20 mg tablet, 30 9231W
APO-AtorvastatinAtorvacholAtorvastatin AmnealAtorvastatin GHAtorvastatin SZAtorvastatin SandozBlooms the Chemist AtorvastatinChem mart AtorvastatinLipitorLorstat 20Pharmacor AtorvastatinTerry White Chemists AtorvastatinTorvastat 20Trovas
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
atorvastatin 40 mg tablet, 30 9232X
APO-AtorvastatinAtorvacholAtorvastatin AmnealAtorvastatin GHAtorvastatin SZAtorvastatin SandozBlooms the Chemist AtorvastatinChem mart AtorvastatinLipitorLorstat 40Pharmacor AtorvastatinTerry White Chemists AtorvastatinTorvastat 40Trovas
53
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
atorvastatin 80 mg tablet, 30 9233Y
APO-AtorvastatinAtorvastatin AmnealAtorvastatin GHAtorvastatin SZAtorvastatin SandozBlooms the Chemist AtorvastatinChem mart AtorvastatinLipitorLorstat 80Pharmacor AtorvastatinTerry White Chemists AtorvastatinTorvastat 80Trovas
carbomer-980 0.2% eye gel, 10 g 9210ROptifresh eye gelPAAViscotears
Severe dry eye syndrome, including Sjogren's syndrome
carmellose sodium 0.5% (5 mg/mL) eye drops, 15 mL 9211T Refresh Tears Plus Severe dry eye syndrome, including Sjogren's
syndromecarmellose sodium 0.5% + glycerol 0.9% eye drops, 15 mL 9356K Optive Severe dry eye syndrome, including Sjogren's
syndromeMedicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)carmellose sodium 1% (10 mg/mL) eye drops, 15 mL 9212W Refresh Liquigel Severe dry eye syndrome, including Sjogren's
syndromecolestyramine 4 g powder for oral liquid, 50 sachets 9249T Questran Lite Primary hypercholesterolaemia
dextran-70 0.1% + hypromellose 0.3% eye drops, 15 mL 9216C Poly-Tears
Tears NaturaleSevere dry eye syndrome, including Sjogren's syndrome
fenofibrate 145 mg tablet, 30 9247Q Lipidil fenofibrate 48 mg tablet, 60 9246P Lipidil fluvastatin 80 mg modified release tablet, 28 9236D Lescol XL
gemfibrozil 600 mg tablet, 60 9248R AusgemLipigem
hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g 9215B HPMC PAA
Genteal gelSevere dry eye syndrome, including Sjogren's syndrome
54
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
hypromellose 0.3% w/w eye drops, 10 mL 11643T In a Wink MoisturisingGenteal
Severe dry eye syndrome, including Sjogren's syndrome
hypromellose 0.3% w/w eye drops, 15 mL 9213X In a Wink MoisturisingGenteal
Severe dry eye syndrome, including Sjogren's syndrome
hypromellose 0.5% eye drops, 15 mL 9214Y Methopt Severe dry eye syndrome, including Sjogren's syndrome
pancreatic extract 25 000 units modified release capsule, 100 9227P Creon 25,000 Cystic fibrosis
pancreatic extract 40 000 units modified release capsule, 100 9413K Creon 40,000 Cystic fibrosis
pancrelipase 25 000 units capsule, 100 9229R Panzytrat 25000 Cystic fibrosispolyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL 9219F Systane Severe dry eye syndrome, including Sjogren's
syndrome
polyvinyl alcohol 1.4% eye drops, 15 mL 9220G PVA TearsLiquifilm Tears
Severe dry eye syndrome, including Sjogren's syndrome
polyvinyl alcohol 1.4% eye drops, 15 mL 9221H Vistil Severe dry eye syndrome, including Sjogren's syndrome
polyvinyl alcohol 3% eye drops, 15 mL 9223K Vistil Forte Severe dry eye syndrome, including Sjogren's syndrome
55
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
pravastatin sodium 10 mg tablet, 30 9237E
APO-PravastatinLipostat 10Pravastatin ANPravastatin SandozPravastatin generichealthPravacholCholstat 10
pravastatin sodium 20 mg tablet, 30 9238F
APO-PravastatinCholstat 20CholvastinLipostat 20Pravastatin ANPravastatin SandozPravastatin generichealthPravachol
pravastatin sodium 40 mg tablet, 30 9239G
APO-PravastatinCholstat 40CholvastinLipostat 40Pravastatin ANPravastatin SandozPravachol
pravastatin sodium 80 mg tablet, 30 9240H
APO-PravastatinLipostat 80Pravastatin ANPravastatin SandozPravastatin generichealthPravachol
retinol palmitate 0.0138% + paraffin eye ointment, 5 g 2202X VitA-POS
56
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
rosuvastatin 10 mg tablet, 30 2584B
APO-RosuvastatinBTC RosuvastatinBlooms the Chemist RosuvastatinCavstatChem mart RosuvastatinCrosuva 10Pharmacor Rosuvastatin 10Rostor 10Rosuvastatin AMNEALRosuvastatin APOTEXRosuvastatin RBXRosuvastatin SandozRosuvastatin generichealthRosuvastatin-DRLATerry White Chemists RosuvastatinCrestor
rosuvastatin 20 mg tablet, 30 2609H
APO-RosuvastatinBTC RosuvastatinBlooms the Chemist RosuvastatinCavstatChem mart RosuvastatinCrosuva 20Pharmacor Rosuvastatin 20Rostor 20Rosuvastatin AMNEALRosuvastatin APOTEXRosuvastatin RBXRosuvastatin SandozRosuvastatin generichealthRosuvastatin-DRLATerry White Chemists RosuvastatinCrestor
57
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
rosuvastatin 40 mg tablet, 30 2636R
APO-RosuvastatinBTC RosuvastatinBlooms the Chemist RosuvastatinCavstatChem mart RosuvastatinCrosuva 40Pharmacor Rosuvastatin 40Rostor 40Rosuvastatin AMNEALRosuvastatin APOTEXRosuvastatin RBXRosuvastatin SandozRosuvastatin generichealthRosuvastatin-DRLATerry White Chemists RosuvastatinCrestor
rosuvastatin 5 mg tablet, 30 2590H
APO-RosuvastatinBTC RosuvastatinBlooms the Chemist RosuvastatinCavstatChem mart RosuvastatinCrosuva 5Pharmacor Rosuvastatin 5Rostor 5Rosuvastatin AMNEALRosuvastatin APOTEXRosuvastatin RBXRosuvastatin SandozRosuvastatin generichealthRosuvastatin-DRLATerry White Chemists RosuvastatinCrestor
58
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
simvastatin 10 mg tablet, 30 9242K
APO-SimvastatinChem mart SimvastatinRansimSimvar 10Simvastatin ANSimvastatin SandozSimvastatin generichealthTerry White Chemists SimvastatinZimstatLipex 10Zocor
simvastatin 20 mg tablet, 30 9243L
APO-SimvastatinChem mart SimvastatinSimvar 20Simvastatin ANSimvastatin SandozSimvastatin generichealthTerry White Chemists SimvastatinZimstatLipex 20Zocor
simvastatin 40 mg tablet, 30 9244M
APO-SimvastatinChem mart SimvastatinSimvar 40Simvastatin ANSimvastatin SandozSimvastatin generichealthTerry White Chemists SimvastatinZimstatZocorLipex 40
simvastatin 5 mg tablet, 30 9241J Simvastatin SandozZimstat
59
Pharmaceutical Benefits Scheme (PBS) August 2018 Meeting - New and Amended Listings for Increased Dispensing Quantities
Medicine (strength & form) Item Code Brand Indication (M=multiple, blank=Unrestricted)
simvastatin 80 mg tablet, 30 9245N
APO-SimvastatinChem mart SimvastatinRansimSimvar 80Simvastatin ANSimvastatin SandozSimvastatin generichealthTerry White Chemists SimvastatinZimstatLipex 80Zocor
sulfasalazine 500 mg enteric tablet, 100 9209Q Pyralin ENSalazopyrin-EN
sulfasalazine 500 mg tablet, 100 9208P Salazopyrin
60